Literature DB >> 24247818

(18)F-DOPA PET/CT for assessment of response to induction chemotherapy in a child with high-risk neuroblastoma.

Arnoldo Piccardo1, Egesta Lopci, Luca Foppiani, Giovanni Morana, Massimo Conte.   

Abstract

Functional imaging plays a crucial role in the assessment of neuroblastoma. The evaluation of response to induction chemotherapy is a cornerstone in scheduling proper treatment management in patients affected by high-risk neuroblastoma. (123)I-metaiodobenzylguanidine has been recognized as the radiopharmaceutical of choice in neuroblastoma assessment. To date, the clinical role of PET/CT in pediatric malignancy is not well established.(18)F-DOPA-PET/CT has been recently used in neuroblastoma, and compared with (123)I-MIBG-scan. Scant new data are available about the role of this tool in the evaluation of treatment response after induction chemotherapy. We investigate the role of (18)F-DOPA-PET/CT in characterizing the response to induction chemotherapy in a child affected by high-risk-neuroblastoma, in whom the rare association of (123)I-MIBG-negative primary tumor and MIBG-positive bone marrow metastases was observed.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24247818     DOI： 10.1007/s00247-013-2807-x

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN： 0301-0449


  8 in total

1.  Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study.

Authors:  Arnoldo Piccardo; Egesta Lopci; Massimo Conte; Alberto Garaventa; Luca Foppiani; Vania Altrinetti; Cristina Nanni; Pietro Bianchi; Angela Cistaro; Stefania Sorrentino; Manlio Cabria; Andrea Pession; Matteo Puntoni; Giampiero Villavecchia; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-20       Impact factor: 9.236

Review 2.  123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis.

Authors:  Arnold F Jacobson; Hsiaowei Deng; John Lombard; Harry J Lessig; Richard R Black
Journal:  J Clin Endocrinol Metab       Date:  2010-04-14       Impact factor: 5.958

3.  18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.

Authors:  Nikolaos D Papathanasiou; Mark N Gaze; Kevin Sullivan; Matthew Aldridge; Wendy Waddington; Ahmad Almuhaideb; Jamshed B Bomanji
Journal:  J Nucl Med       Date:  2011-03-18       Impact factor: 10.057

Review 4.  Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

Authors:  K K Matthay; B Shulkin; R Ladenstein; J Michon; F Giammarile; V Lewington; A D J Pearson; S L Cohn
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

5.  Refining interpretation of MIBG scans in children.

Authors:  F Bonnin; J Lumbroso; F Tenenbaum; O Hartmann; C Parmentier
Journal:  J Nucl Med       Date:  1994-05       Impact factor: 10.057

6.  Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma.

Authors:  Howard M Katzenstein; Susan L Cohn; Richard M Shore; Dianna M E Bardo; Paul R Haut; Marie Olszewski; Jennifer Schmoldt; Dachao Liu; Alfred W Rademaker; Morris Kletzel
Journal:  J Clin Oncol       Date:  2004-10-01       Impact factor: 44.544

7.  Characterization of neuroblastic tumors using 18F-FDOPA PET.

Authors:  Meng-Yao Lu; Yen-Lin Liu; Hsiu-Hao Chang; Shiann-Tarng Jou; Yung-Li Yang; Kai-Hsin Lin; Dong-Tsamn Lin; Ya-Ling Lee; Hsinyu Lee; Pei-Yi Wu; Tsai-Yueh Luo; Lie-Hang Shen; Shiu-Feng Huang; Yung-Feng Liao; Wen-Ming Hsu; Kai-Yuan Tzen
Journal:  J Nucl Med       Date:  2012-12-04       Impact factor: 10.057

8.  Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.

Authors:  Katherine K Matthay; Veronique Edeline; Jean Lumbroso; Marie Laure Tanguy; Bernard Asselain; Jean Michel Zucker; Dominique Valteau-Couanet; Olivier Hartmann; Jean Michon
Journal:  J Clin Oncol       Date:  2003-07-01       Impact factor: 44.544
  8 in total
  2 in total

1.  Biodistribution and Dosimetry of 18F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies.

Authors:  Neeta Pandit-Taskar; Pat Zanzonico; Kevin D Staton; Jorge A Carrasquillo; Diane Reidy-Lagunes; Serge Lyashchenko; Eva Burnazi; Hanwen Zhang; Jason S Lewis; Ronald Blasberg; Steven M Larson; Wolfgang A Weber; Shakeel Modak
Journal:  J Nucl Med       Date:  2017-07-13       Impact factor: 10.057

Review 2.  Norepinephrine Transporter as a Target for Imaging and Therapy.

Authors:  Neeta Pandit-Taskar; Shakeel Modak
Journal:  J Nucl Med       Date:  2017-09       Impact factor: 10.057
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.